Sastasundar ventures has announced a significant share transaction involving its material subsidiary Sastasundar Healthbuddy Limited (SHBL). The company disclosed under Regulation 30 of SEBI regulations that a Share Purchase Agreement was executed on February 25, 2026, facilitating a stake transfer between institutional investors.

Transaction Details

The share purchase agreement involves three parties: Sastasundar Healthbuddy Limited, Mitsubishi Corporation as the seller, and Envision India Fund as the buyer. The transaction parameters are structured as follows:

Regulatory Compliance

Health X Platform Limited, formerly known as Sastasundar Ventures Limited, received the transaction intimation from its material subsidiary SHBL on February 25, 2026 at 7:57 P.M. The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Impact on Shareholding Structure

Upon completion of this acquisition, Mitsubishi Corporation will cease to be a shareholder of Sastasundar Healthbuddy Limited. The transaction is subject to the satisfaction of agreed terms and conditions as stipulated in the Share Purchase Agreement. Envision India Fund will acquire the 4.68% stake, representing a significant institutional investment in the healthcare subsidiary.

Corporate Structure

Sastasundar Healthbuddy Limited operates as a material subsidiary of Health X Platform Limited. The parent company maintains its listing status and continues to fulfill disclosure obligations regarding material developments in its subsidiaries. The transaction demonstrates ongoing investor interest in the healthcare technology sector, with institutional funds actively participating in stake acquisitions.

Sastasundar ventures has disclosed multiple share acquisitions by its promoter under SEBI insider trading regulations. The company has informed BSE and NSE about these transactions through formal disclosures, demonstrating continued promoter confidence in the company.

Recent Promoter Share Acquisitions

Promoter Banwari Lal Mittal has made two separate acquisitions of equity shares through market purchases. The first transaction was executed on 11.02.2026, followed by another acquisition on 18.02.2026, both intimated to the company on their respective transaction dates.

Transaction Summary

The market purchases involved a total of 13,000 equity shares across two transactions with a combined transaction value of Rs. 38,68,525.02, inclusive of taxes. These acquisitions represent a strategic increase in the promoter's stake in the company.

Progressive Shareholding Changes

The cumulative effect of both transactions shows a steady increase in promoter shareholding, reflecting continued confidence in the company's prospects.

Regulatory Compliance

Both disclosures were made pursuant to Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. Company Secretary and Compliance Officer Pratap Singh submitted the required Form C to both BSE (Stock Code: 533259) and NSE (Symbol: SASTASUNDR) for each transaction.

The company confirmed that no derivative trading was involved in either transaction, with all derivative-related fields marked as "N.A." in the regulatory filings. These acquisitions strengthen the promoter's position in Sastasundar Ventures Limited while maintaining full regulatory compliance throughout both transactions.